Matthew Larson Foundation for Pediatric Brain Tumors

Information for Grant Applicants

The Matthew Larson Foundation for Pediatric Brain Tumor Research seeks to fund translational and clinical projects in Pediatric Brain Tumor Research.   To be considered for the 2018 awards, a Letter of Intent must be received by November 1, 2017.  No extensions on that timeframe will be granted.

Please see the requirements for the Letter of Intent.  Successful applicants will be invited to submit a formal application after the Letter of Intent is reviewed. 

All Letters of Intent and Applications must demonstrate relevance to the purpose of the fund.   

The Foundation uses a peer-reviewed process to identify the merit of proposed projects.  The Medical Advisory Committee serves as the review committee and acts in an advisory capacity to the Board. 

All decisions of the Board are final and not subject to appeal. All applicants will be notified of final decisions.  The Foundation is under no obligation to give comments about applications not funded.

The Primary Investigator on the application must be an MD or PhD at a not-for-profit, medical or scientific institution and must hold an academic rank of assistant professor (or equivalent) or instructor (or equivalent.)   Investigators at higher ranks are excluded.  Investigators at multiple institutions are invited to submit joint applications as long as both institutions give permission and agree to abide by all Foundation requirements.  

Grants will not exceed $75,000 over a one year period. 

A brief progress report is required at the end of the funding period.  Failure to file this report will exclude the investigator and potentially the investigator’s institution from future applications to the Matthew Larson Foundation for Pediatric Brain Tumor Research. 

Grants will be announced by April 1, 2018 for a one-year funding period starting May 1, 2018.

Funds may be used for new or existing research projects but all sources of funding for the project, including those pending, must be disclosed to the Foundation.  Prior and current funding for the principal investigator must also be disclosed.

Only direct costs will be funded.  No indirect or other institutional costs will be funded.  Salaries, equipment and supplies will be allowed as long as they are direct costs of the project.  Salary support must match percentage effort.  Travel funding is specifically excluded. 

The funds must be kept segregated from other research funds to ensure accurate and timely financial reporting of the research project. 

Funding by the Matthew Larson Foundation for Pediatric Brain Tumor Research must be acknowledged in all presentations and publications of funded research projects. 

Failure to follow these guidelines in their entirety will eliminate the applicant from the process.